Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis (Q36283486)

13 August 2017

1 reference

title

Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis (English)

1 reference

13 August 2017

1 reference

5

Y Shoenfeld

1 reference

13 August 2017

1

E Matsuura

1 reference

13 August 2017

K Kobayashi

2

1 reference

PubMed ID

16218478

13 August 2017

K Inoue

series ordinal

3

1 reference

PubMed ID

16218478

13 August 2017

L R Lopez

series ordinal

4

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

14

1 reference

13 August 2017

9

1 reference

13 August 2017

736-741

1 reference

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

13 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Low density lipoprotein oxidation and its pathobiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2211OA

10.1191/0961203305LU2211OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16218478